US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 123.450
  • +1.810+1.49%
Close Dec 4 16:00 ET
  • 123.450
  • 0.0000.00%
Post 16:20 ET
7.46BMarket Cap17.49P/E (TTM)

Jazz Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jazz Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.04B
1.05B
+18.43M
Beat Est.
+6.62%
+8.52%
+1.78%
EPS
2.20
3.42
+1.22
Beat Est.
+2.69%
+59.81%
+55.62%
Analyst Rating
Strong Buy

Nov 30, 2024

Jazz Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 987.697M--
--2024/Q4-- / 1.057B--
Nov 6, 20242024/Q31.055B / 1.037B--
Jul 31, 20242024/Q21.024B / 1.004B--
May 1, 20242024/Q1901.983M / 954.321M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 987.697M--
--2024/Q4-- / 1.057B--
Nov 6, 20242024/Q31.055B / 1.037B--
Jul 31, 20242024/Q21.024B / 1.004B--
May 1, 20242024/Q1901.983M / 954.321M--

Unlock Free Earnings Estimates

Jazz Pharmaceuticals Earnings Reports

  • Jazz Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:33 ET

  • Jazz Pharmaceuticals | 8-K: Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results

    Nov 6 16:08 ET

  • Jazz Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:36 ET

  • Jazz Pharmaceuticals | 8-K: Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance

    Jul 31 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data